SCHEMBL4166429

SCHEMBL4166429

Cc1cc(C)c(S(=O)(=O)N[C@H]2CCCNC2)c(C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 3/20 0.51
BRD2 P25440 2/20 0.51
BRD3 Q15059 2/20 0.51
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
MMP1 P03956 1/20 0.42
MMP2 P08253 1/20 0.42
MMP9 P14780 1/20 0.42
MMP8 P22894 1/20 0.42
MMP13 P45452 1/20 0.42
ALDH1A1 P00352 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
CYP3A4 P08684 1/20 0.40
TSHR P16473 1/20 0.40
IKBKB O14920 1/20 0.39
JAK2 O60674 1/20 0.39
ROCK2 O75116 1/20 0.39
JAK1 P23458 1/20 0.39
TYK2 P29597 1/20 0.39
JAK3 P52333 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5593184 0.82 BRD4 (0.53) BRD4BRD2BRD3ALDH1A1SMN1; SMN2
SCHEMBL8490919 0.82 ALDH1A1 (0.58) CA1CA2MMP1MMP2MMP9
SCHEMBL995294 0.78 ALDH1A1 (0.68) BRD4BRD2BRD3ALDH1A1SMN1; SMN2
SCHEMBL17277267 0.78 ALDH1A1 (0.68) BRD4BRD2BRD3ALDH1A1SMN1; SMN2
SCHEMBL17277312 0.78 ALDH1A1 (0.68) BRD4BRD2BRD3ALDH1A1SMN1; SMN2
SCHEMBL27422587 0.76 BRD4 (0.58) BRD4BRD2BRD3ALDH1A1SMN1; SMN2
SCHEMBL27422584 0.76 BRD4 (0.58) BRD4BRD2BRD3ALDH1A1SMN1; SMN2
SCHEMBL10797764 0.75 APLNR (0.46) CA1CA2MMP1MMP2MMP9
SCHEMBL4668508 0.74 ALDH1A1 (0.70) ALDH1A1SMN1; SMN2CYP3A4TSHRKMT2A
SCHEMBL3976452 0.74 EHMT2 (0.45) BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090170898-A1 Sulphonamide Derivatives as Modulators of the Glucocorticoid Receptor BENGTSSON MALENA 2009-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170898-A1 Sulphonamide Derivatives as Modulators of the Glucocorticoid Receptor NR3C1, NR3C2, NR5A1 BRD4 2260/4885BRD2 1912/4885BRD3 1730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.